awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35144007-CCC4E68D-7E1F-497F-BF3C-03471A8A2D36
Q35144007-CCC4E68D-7E1F-497F-BF3C-03471A8A2D36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35144007-CCC4E68D-7E1F-497F-BF3C-03471A8A2D36
Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
P2860
Q35144007-CCC4E68D-7E1F-497F-BF3C-03471A8A2D36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35144007-CCC4E68D-7E1F-497F-BF3C-03471A8A2D36
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e9642669ac9e420d4ef180a56fc4ad7157209f6a
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.